Alopecia in Anticoagulated Patients

January 2020 in “ Jornal Vascular Brasileiro ”

Marcos Arêas Marques, Carmen Lúcia Lascasas Porto, Ana Letícia de Matos Milhomens, Juliana de Miranda Vieira, Claudia Carvalho Alcântara Gomes, Ana Thereza Rocha, Cíntia da Silva Miller

alopecia anticoagulant therapy hair loss frontotemporal area scalp dermatological treatment skin treatment

Studysummary This review discusses the mechanisms behind alopecia during anticoagulation therapy and current treatments but reports no new clinical results.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on scielo.br →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research Off-Label Use of Topical Minoxidil in Alopecia: A Review

32 citations , January 2019 in “American Journal of Clinical Dermatology”

This review discusses the use of topical minoxidil for various types of alopecia and reports mixed evidence on its efficacy, with stronger support noted for conditions like eyebrow hypotrichosis and chemotherapy-induced alopecia.

research Non-Hemorrhage-Related Adverse Effects of Rivaroxaban

13 citations , December 2017 in “Archives of Medical Sciences”

This article highlights that rivaroxaban, commonly associated with bleeding risks, may also cause rare non-bleeding adverse effects like liver injury and hypersensitivity.

research Agent-Specific Effects of Anticoagulant-Induced Alopecia

7 citations , May 2017 in “Research and Practice in Thrombosis and Haemostasis”

This case report observed that a 20-year-old female with recurrent DVTs experienced reversible alopecia with various anticoagulants, except fondaparinux which allowed long-term treatment without this side effect.

research Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature

31 citations , January 2016 in “Drugs - Real World Outcomes”

This review discusses the potential link between direct oral anticoagulants and hair loss, suggesting DOACs may not be a suitable alternative for patients with alopecia from traditional anticoagulants; however, no clinical results are reported.

research Rivaroxaban-Induced Hair Loss

8 citations , August 2015 in “European Journal of Clinical Pharmacology”

This case report suggests that hair loss may be a potential adverse effect of rivaroxaban, though it is not listed in the product characteristics.

research Androgenetic Alopecia: An Evidence-Based Treatment Update

151 citations , May 2014 in “American Journal of Clinical Dermatology”

This review concluded that oral finasteride for men and topical minoxidil for both genders have the most evidence supporting their effectiveness and safety for treating androgenetic alopecia.

research Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden NOAC Registry (NCT01588119)

8 citations , November 2012 in “Blood”

This study observed that the incidence of hair loss as a spontaneously reported side effect of novel oral anticoagulant therapy is approximately 4.4 per 100 patient years.

research Drugs and Hair Loss: Mechanisms and Clinical Implications

54 citations , September 2012 in “Dermatologic Clinics”

This review discusses possible medication-induced hair loss and the need to exclude other confounding factors like stress and illness; it reports no new clinical findings and emphasizes careful assessment before attributing hair loss to medications.

research Enoxaparin-Induced Alopecia in Patients with Cerebral Venous Thrombosis

26 citations , August 2006 in “Journal of Clinical Pharmacy and Therapeutics”

This study reported that enoxaparin may cause alopecia in patients treated for cerebral venous thrombosis, with hair growth resuming naturally after the treatment ended.